Professor Daniel MacArthur was interviewed on ABC Nightlife about genomic medicine guiding the future of health. Listen now: https://ow.ly/t3Mj50Q5i3Q
Garvan Institute of Medical Research
調査サービス
Darlinghurst、NSW19,606人のフォロワー
Our medical research will transform healthcare. We explore the full spectrum of disease to live life to the fullest.
概要
For more than 50 years the Garvan Institute of Medical Research has pioneered insights into some of the most widespread diseases affecting our community today. Garvan's mission is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Garvan strives to enhance and develop research programs that combine fundamental science with strong clinical interactions. Research at Garvan is focused upon understanding the role of genes and molecular and cellular processes in health and disease as the basis for developing future preventions, treatments and cures. For over 50 years, significant breakthroughs have been achieved by Garvan scientists in the understanding and treatment of diseases such as: * Cancer * Diabetes and obesity * Neurological diseases such as Alzheimer's, Parkinson's, hearing loss, mental illnesses and eating disorders * Osteoporosis * Immunological diseases such as asthma, rheumatoid arthritis, multiple sclerosis and Sjogren's syndrome Garvan's ultimate goal is prevention, treatment or cure of these major diseases.
- ウェブサイト
-
http://www.garvan.org.au
Garvan Institute of Medical Researchの外部リンク
- 業種
- 調査サービス
- 会社規模
- 社員 501 - 1,000名
- 本社
- Darlinghurst、NSW
- 種類
- 非営利団体
- 創立
- 1963
- 専門分野
- cancer、osteoporosis、immunology、neurodegenerative diseases、diabetes & obesity、genomics、cellular genomics
場所
-
プライマリ
384 Victoria Street
Darlinghurst、NSW、2010、AU
Garvan Institute of Medical Researchの社員
アップデート
-
The Optus outage currently impacts Garvan phones. In the meantime, please contact us via foundation@garvan.org.au for any enquiries. For information on the outage: https://ow.ly/VPTb50Q5iGI
Optus services 'gradually' restored as engineers warn of network vulnerabilities — as it happened
abc.net.au
-
We're #hiring a new Software Lead in Australia. Apply today or share this post with your network.
-
Garvan's A/Prof Liz Caldon was interviewed by Channel 7 on identifying new genetic tests that can predict which cancer patients are likely to benefit from combination therapy. Watch here: https://lnkd.in/e_9YQX7a
New genetic test identifying patients who benefit from new cancer therapy | 7 News Australia
https://www.youtube.com/
-
By analysing more than 80 clinical trials, researchers at Garvan have identified genetic tests that predict which cancer patients are likely to benefit from PARP inhibitors in combination with chemotherapy. “Our research indicates that genetic testing of cancers can predict how a patient will respond to PARP inhibitors when used with other cancer therapies, to help guide more personalised therapy for patients,” says Associate Professor Caldon. Read more: https://ow.ly/8bnj50Q3Mkt
-
Garvan researcher Dr Deborah Burnett has received one of five prestigious 2023 L’Oréal-UNESCO For Women in Science Fellowships, to support her cutting-edge research investigating the immune mechanisms behind Guillain-Barré syndrome. Read more: https://ow.ly/sZj250Q4mqF
-
Congratulations Dr Mandy Ballinger for being internationally recognised with the 2023 Liddy Shriver Early Career Research Award. This award was given for her outstanding research contributions in the field of sarcoma. Read more: https://ow.ly/icuH50Q4moj
-
Did you miss our Breast Cancer Public Lecture last week? Catch up with our online recording and hear from award-winning researchers and clinicians on new treatments, overcoming drug resistance, preventing metastasis, and promising clinical trials. Learn more: https://ow.ly/830I50Q3hSo
Breast Cancer Public Seminar - 2023
https://www.youtube.com/
-
November is pancreatic cancer awareness month. Recently, a team at Garvan found that a key cancer driver molecule, that is often overly active in pancreatic cancer, could be used to reveal new paths to tackling drug resistance with combination therapies. “Thanks to our new imaging model, we can see a clear way forward for how combination approaches could reduce drug resistance and help stop tumours from growing and spreading," says Professor Paul Timpson. Learn more: https://ow.ly/4o8e50Q3JIH
Live drug response in pancreatic cancer
https://www.youtube.com/
-
A study led by researchers at Garvan has revealed for the first time a gene called RELA, known to regulate inflammation, also plays an essential role in maintaining normal blood-sugar levels. “This could lead to the development of medications that reduce inflammation without bringing on steroid-induced diabetes as a side effect,” says Professor Grey. Learn more: https://ow.ly/MOjh50Q3hKb
Gene provides clues for preventing common diabetes side effect of corticosteroid treatment
https://www.youtube.com/